As of 2026-09-23, the Fair Value of Spruce Biosciences Inc (SPRB) is -67.62 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 49.99 USD, the upside of Spruce Biosciences Inc is -235.27%.
With the market price of 49.99 USD and our fair value calculation, Spruce Biosciences Inc (SPRB) is not a good investment. Investing in SPRB stocks now will result in a potential loss of 235.27%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | -42.29 | -46.18 | -47.92 | -53.04 | -38.97 | -45.68 |
| YoY growth | -43.17% | -9.19% | -3.77% | -10.68% | 26.53% | -8.06% |
| Market Cap (mil) | 137.47 |
| P/E | |
| Forward P/E |
| EPS | -13.52 |
| Avg earnings growth rate | -8.06% |
| TTM earnings | -37.19 |